Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117396032 | 11739603 | 2 | F | 20090315 | 20160131 | 20151113 | 20160804 | EXP | UG-BRISTOL-MYERS SQUIBB COMPANY-14902605 | BRISTOL MYERS SQUIBB | 27.00 | YR | F | Y | 0.00000 | 20160804 | OT | UG | UG |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117396032 | 11739603 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Oral | 600 MG, QD | 624600 | MG | Y | 20972 | 600 | MG | QD | ||||
| 117396032 | 11739603 | 2 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 300 MG, QD | 336300 | MG | Y | 0 | 300 | MG | QD | ||||
| 117396032 | 11739603 | 3 | SS | VIRAMUNE | NEVIRAPINE | 1 | Oral | 400 MG, QD | 27200 | MG | Y | 0 | 400 | MG | QD | ||||
| 117396032 | 11739603 | 4 | SS | EPIVIR | LAMIVUDINE | 1 | Oral | 300 MG, QD | 0 | 300 | MG | QD | |||||||
| 117396032 | 11739603 | 5 | SS | ZIAGEN | ABACAVIR SULFATE | 1 | Oral | 600 MG, QD | 0 | 600 | MG | QD | |||||||
| 117396032 | 11739603 | 6 | SS | ALUVIA | LOPINAVIRRITONAVIR | 1 | Oral | 1000 MG, QD | 0 | 1000 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117396032 | 11739603 | 1 | Antiretroviral therapy |
| 117396032 | 11739603 | 2 | Antiretroviral therapy |
| 117396032 | 11739603 | 3 | Antiretroviral therapy |
| 117396032 | 11739603 | 4 | Antiretroviral therapy |
| 117396032 | 11739603 | 5 | Antiretroviral therapy |
| 117396032 | 11739603 | 6 | Antiretroviral therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117396032 | 11739603 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117396032 | 11739603 | Abortion spontaneous | |
| 117396032 | 11739603 | Maternal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117396032 | 11739603 | 1 | 20060206 | 20081212 | 0 | |
| 117396032 | 11739603 | 2 | 20060207 | 20090303 | 0 | |
| 117396032 | 11739603 | 3 | 20081226 | 20090303 | 0 | |
| 117396032 | 11739603 | 4 | 20051213 | 0 | ||
| 117396032 | 11739603 | 5 | 20090303 | 0 | ||
| 117396032 | 11739603 | 6 | 20090303 | 0 |